Literature DB >> 4213715

Nosocomial infections due to Pseudomonas.

J V Bennett.   

Abstract

Entities:  

Mesh:

Year:  1974        PMID: 4213715     DOI: 10.1093/infdis/130.supplement.s4

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  19 in total

1.  EVALUATION OF HOSPITAL ACQUIRED PSEUDOMONAS INFECTION IN PARAPLEGIC AND ORTHOPAEDIC CASES.

Authors:  K K Lahiri
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Genome fingerprinting by pulsed-field gel electrophoresis and ribotyping to differentiate Pseudomonas aeruginosa serotype O11 strains.

Authors:  C L Poh; C C Yeo; L Tay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

3.  Heavy metal resistance in clinical isolates of Pseudomonas aeruginosa.

Authors:  R Vasishta; S Chhibber; M Saxena
Journal:  Folia Microbiol (Praha)       Date:  1989       Impact factor: 2.099

4.  Column chromatography and cell culture assay of Pseudomonas aeruginosa toxin Z preparations.

Authors:  P P Ludovici; F A Roinestad; F S Wong
Journal:  Appl Microbiol       Date:  1975-08

5.  Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.

Authors:  N J Legakis; M Aliferopoulou; J Papavassiliou; M Papapetropoulou
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

6.  Effect of cyclophosphamide on the immune response to Pseudomonas aeruginosa in mice.

Authors:  C L Pierson; A G Johnson; I Feller
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Differential primary plating medium for enhancement of pigment production by Pseudomonas aeruginosa.

Authors:  J A Daly; R Boshard; J M Matsen
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

8.  Gentamicin use and Pseudomonas and Serratia resistance: effect of a surgical prophylaxis regimen.

Authors:  N J Roberts; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

9.  A three-year study of nosocomial infections associated with Pseudomonas aeruginosa.

Authors:  R J Sherertz; F A Sarubbi
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

10.  Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa.

Authors:  H J Zweerink; M C Gammon; C F Hutchison; J J Jackson; D Lombardo; K M Miner; J M Puckett; T J Sewell; N H Sigal
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.